The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Centessa Pharmaceuticals plc ADR shares valued at $165,835 were sold by HUSSAIN IQBAL J on Nov 17 ’25. At $27.64 per share, HUSSAIN IQBAL J sold 6,000 shares. The insider’s holdings dropped to 105,386 shares worth approximately $2.9 million following the completion of this transaction.
Also, Bush Tia L sold 40,000 shares, netting a total of over 1,120,000 in proceeds. Following the sale of shares at $28.00 each, the insider now holds 121,503 shares.
Before that, Bush Tia L had added 40,000 shares to its account. In a trade valued at $1,120,000, the Officer bought Centessa Pharmaceuticals plc ADR shares for $28.00 each.
As published in their initiating research note from Stephens on October 28, 2025, Centessa Pharmaceuticals plc ADR [CNTA] has been an Overweight and the price target has been revised to $35. Analysts at Wells Fargo started covering the stock with ‘”an Overweight”‘ outlook in a report released in early September. Earlier on July 21, 2025, Truist initiated its rating. Their recommendation was “a Buy” for CNTA stock.
Analyzing CNTA Stock Performance
On last trading session, Centessa Pharmaceuticals plc ADR [NASDAQ: CNTA] plunged -1.64% to $27.54. The stock’s lowest price that day was $27.48, but it reached a high of $29.33 in the same session. During the last five days, there has been a surge of approximately 6.05%. Over the course of the year, Centessa Pharmaceuticals plc ADR shares have jumped approximately 71.06%. Shares of the company reached a 52-week high of $29.33 on 11/20/25 and a 52-week low of $9.60 on 04/09/25.
Support And Resistance Levels for Centessa Pharmaceuticals plc ADR (CNTA)
According to the 24-hour chart, there is a support level at 26.90, which, if violated, would cause prices to drop to 26.25. In the upper region, resistance lies at 28.76. The next price resistance is at 29.97. RSI (Relative Strength Index) is 64.28 on the 14-day chart, showing neutral technical sentiment.
Is Centessa Pharmaceuticals plc ADR subject to short interest?
Stocks of Centessa Pharmaceuticals plc ADR saw a sharp rise in short interest on 2025-10-31 jumping by 0.16 million shares to 5.15 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 4.99 million shares. A jump of 3.14% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 5.38 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.38.
Which companies own the most shares of Centessa Pharmaceuticals plc ADR (CNTA)?
In terms of Centessa Pharmaceuticals plc ADR share price expectations, FactSet research, analysts set an average price target of 31 in the next 12 months, up nearly 10.71% from the previous closing price of $28.0. Analysts anticipate Centessa Pharmaceuticals plc ADR stock to reach 35 by 2025, with the lowest price target being 30. In spite of this, 6 analysts ranked Centessa Pharmaceuticals plc ADR stock as Buy at the end of 2025. On May 28, 2025, Needham assigned a price target of “a Buy” to the stock and initiated coverage with a $35.
